Retour
Fourchette du Jour
61,56 €
63,17 €
Fourchette 52 Semaines
57,25 €
89,37 €
Volume
414 667
Moyenne 50J / 200J
65,70 €
/
67,08 €
Clôture Précédente
60,99 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 14,1 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | 12,3 | 3,7 |
| Net Margin % | 18,9 | 3,8 |
| Rev Growth 5Y % | 4,8 | 10,0 |
| D/E | 0,6 | 0,2 |
Points Clés
Revenue grew 4,80% annually over 5 years — modest growth
ROE of 12,30% — decent returns on equity
Net margin of 18,86% shows strong profitability
Generating 243,29M in free cash flow
P/E of 14,07 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,70%
Croissance
Revenue Growth (5Y)
4,80%
Revenue (1Y)1,10%
Earnings (1Y)2,52%
FCF Growth (3Y)4,70%
Qualité
Return on Equity
12,30%
ROIC8,77%
Net Margin18,86%
Op. Margin29,60%
Sécurité
Debt / Equity
0,57
Current Ratio4,20
Interest Coverage7,07
Valorisation
P/E Ratio
14,07
P/B Ratio1,65
EV/EBITDA11,77
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,10% | Revenue Growth (3Y) | 0,44% |
| Earnings Growth (1Y) | 2,52% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4,80% | Earnings Growth (5Y) | 6,84% |
| Profitability | |||
| Revenue (TTM) | 1,14B | Net Income (TTM) | 214,61M |
| ROE | 12,30% | ROA | 6,31% |
| Gross Margin | 55,76% | Operating Margin | 29,60% |
| Net Margin | 18,86% | Free Cash Flow (TTM) | 243,29M |
| ROIC | 8,77% | FCF Growth (3Y) | 4,70% |
| Safety | |||
| Debt / Equity | 0,57 | Current Ratio | 4,20 |
| Interest Coverage | 7,07 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 14,07 | P/B Ratio | 1,65 |
| P/S Ratio | 2,65 | PEG Ratio | 7,62 |
| EV/EBITDA | 11,77 | Dividend Yield | 0,00% |
| Market Cap | 3,02B | Enterprise Value | 3,97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,14B | 1,13B | 1,13B | 1,09B | 943,37M |
| Net Income | 214,61M | 209,34M | -82,31M | 205,38M | 164,68M |
| EPS (Diluted) | 4,29 | 4,17 | -1,65 | 4,04 | 3,25 |
| Gross Profit | 634,46M | 624,45M | 625,29M | 620,65M | 547,47M |
| Operating Income | 336,78M | 342,43M | -22,42M | 329,92M | 297,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,40B | 3,32B | 3,35B | 3,67B | 3,43B |
| Total Liabilities | 1,57B | 1,66B | 1,91B | 2,09B | 2,07B |
| Shareholders' Equity | 1,83B | 1,66B | 1,45B | 1,58B | 1,36B |
| Total Debt | 1,04B | 1,14B | 1,37B | 1,51B | 1,51B |
| Cash & Equivalents | 97,88M | 46,47M | 58,49M | 27,19M | 32,30M |
| Current Assets | 448,33M | 375,04M | 391,74M | 293,27M | 269,84M |
| Current Liabilities | 106,62M | 117,05M | 160,72M | 143,42M | 122,14M |